Pfizer Endometriosis Pain Drug Gets OK'd
Key points
- Pfizer Inc. said on Tuesday it has received U.S. regulatory approval to sell a drug to treat the pain associated with endometriosis, a condition in which tissue from the uterus migrates and implants in other areas of the body.
- The injectable drug, depo-subQ provera 104, contains the same active ingredient as the contraceptive Depo-Provera, but in a new formulation.
- One of the biggest symptoms of endometriosis is pelvic pain.
- Pfizer said clinical data shows its drug is as effective in treating pain as Lupron Depot, a common existing treatment, but causes a lower incidence of menopausal symptoms such as hot flashes.
Pfizer Inc. said on Tuesday it has received U.S. regulatory approval to sell a drug to treat the pain associated with endometriosis, a condition in which tissue from the uterus migrates and implants in other areas of the body.
The injectable drug, depo-subQ provera 104, contains the same active ingredient as the contraceptive Depo-Provera, but in a new formulation.
One of the biggest symptoms of endometriosis is pelvic pain. Pfizer said clinical data shows its drug is as effective in treating pain as Lupron Depot, a common existing treatment, but causes a lower incidence of menopausal symptoms such as hot flashes.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.